Thursday, February 13, 2020 1:20:34 PM
THE GOOD
"All new physicians being trained on CaverStem® and FemCelz® simultaneously."
"Shared the data under non-disclosure with leading providers around the country."
Guess we have to take his word on this.
THE BAD
"Numerous inquiries from healthcare professionals interested in becoming providers with three new providers committing in January."
Define numerous please!
If they knew 2.0 results were going to be positive, why weren't docs being trained and ready to go on release of trial results?? They should have had more lined up and ready to go. Especially internationally. What happened to Ohio, New York, Tennessee, other countries...?
"Record breaking kit orders in January from new and existing providers"
Technically, one more than the previous month is "record breaking".
THE UGLY
"Additional outreach to consumers"
Where? Due to poor marketing and SEO, the Caverstem and FemCelz treatments cannot be found online by potential patients. The only ones that currently know about these treatments are investors.
"Mailers and Email"?? 90% of people will use a cell phone to do a web search for a "stem cell treatment for erectile dysfunction". Their SEO sucks and they will have to pay a ton of money into Google AdWords to out-rank or somewhat compete with NuMale, Gainswaive and others.
CMTH has never been clear with a business plan.
STEM-SPINE
Sure would be nice to understand the business model on how they intend to generate revenue from StemSpine. Is it only more needle sales? StemSpine, IMO, will be much bigger than Caverstem.
CMTH "ENGAGED with high profile celebrities to serve as brand ambassadors with several INTERESTED parties from professional sports."
This remains to be seen. Nothing solid here. Sounds like speculation.
There is "Promise" for the future. Unfortunately, again In My Opinion, the way they currently operate and slowly progress, there is much more dilution and another R/S in the future.
Many of us longs got sucked in to the hype and misleading PR's over the past two years. No business plan then, no clear business model now. "Self sufficiency" is a long way away!
Recent CELZ News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 08:45:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/25/2024 08:10:25 PM
- Creative Medical Technology Holdings Initiates Development of AI-Driven Diagnostic and Treatment Program for Biologic and Chemical Exposure Utilizing its Validated iPSC Personalized Medicine Program • GlobeNewswire Inc. • 07/24/2024 01:00:39 PM
- Creative Medical Technology Holdings Provides Corporate Update • GlobeNewswire Inc. • 07/10/2024 12:30:00 PM
- Creative Medical Technology Holdings Announces Evolutionary Development of its iPSCelz® Program with the Successful Generation of iPSC Derived Islet Cells that Produce Human Insulin • GlobeNewswire Inc. • 06/24/2024 12:30:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/05/2024 08:05:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:02:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:45:39 PM
- Creative Medical Technology Holdings Provides Corporate Update • Business Wire • 03/27/2024 01:00:00 PM
- Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access • Business Wire • 03/07/2024 02:15:00 PM
- Biotech Finds Mid-Week Success Following FDA Announcement • AllPennyStocks.com • 03/06/2024 09:10:00 PM
- Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy • Business Wire • 03/06/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 09:05:37 PM
- Creative Medical Technology Holdings Provides Corporate Update • PR Newswire (US) • 11/15/2023 01:00:00 PM
- Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain • PR Newswire (US) • 10/10/2023 12:00:00 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM